Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-241-3 | CAS number: 5332-73-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 March 1988 - 14 June 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Remarks:
- GLP study performed according to a method similar to OECD guideline 474 without significant deviations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3-methoxypropylamine
- EC Number:
- 226-241-3
- EC Name:
- 3-methoxypropylamine
- Cas Number:
- 5332-73-0
- Molecular formula:
- C4H11NO
- IUPAC Name:
- 3-methoxypropan-1-amine
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 5601-98-1, Order #88-004
- Substance type: clear colorless liquid
- Physical state: liquid
- Analytical purity: responsibility of the Sponsor
- Lot/batch No.: Order #88-004, recieved on March 25, 1988
- Stability under test conditions: no apparent change in its physical state
- Storage condition of test material: room temperature
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Wilmington, Massachusetts
- Age at study initiation: 7 weeks
- Weight at study initiation: males: 28-32g, females: 22-27g
- Assigned to test groups randomly: yes, randomized by bodyweight, assigned to groups by use of a random number table
- Fasting period before study: no
- Housing: 5 per cage (according to sex and dose group)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 30 - 70%
- Air changes (per hr): no info
- Photoperiod (hrs dark / hrs light): 12 h dark/ 12 h light
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: distilled water
- Details on exposure:
- one single intraperitoneal dose per mouse at a volume of 10 mL/kg body weight
- Duration of treatment / exposure:
- 1 single dose
- Frequency of treatment:
- once
- Post exposure period:
- test substance: 30, 48 and 72h
positive control: 30h
negative control: 48h
Doses / concentrations
- Dose / conc.:
- 75 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - triethylenemelamine
- Route of administration: intraperitoneal
- Doses / concentrations: 0.5 mg/kg
Examinations
- Tissues and cell types examined:
- bone marrow of femur
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Based on dose range finding study with following doses: 10, 50, 100, 200, 500, 1000 and 2000 mg/kg bw .
All mice died from 200 mg/kg bw up to 2000 mg/kg bw dose groups. Due to the mortality observed and the appearance of mild to severe pharmacotoxic signs in the 100 mg/kg bw dose group, 75 mg/kg bw was selected as an estimate of the maximum tolerated dose.
DETAILS OF SLIDE PREPARATION:
All mice were sacrified by cervical dislocation. Femora were opened carefully at the proximal end with a scissors until a small opening to the marrow canal became visible. A 1 ml tuberculin syringe filled with approx. 0.2 ml fetal bovine serum was inserted into the marrow cavity and the marrow was gently flushed (to assure maximum dispersion) into 1.0 ml of fetal bovine serum in a 3 ml conical centrifuge tube. The femora were flushed with fetal bovine serum until all the marrow was out and the bone appeared almost translucent. The suspension was centrifuged at 1000 rpm for 5 minutes. The supernatant was removed leaving a small amount of fetal bovine serum with the remaining cell button. The button was mixed with a pasteur pipette to assure a homogenous mixture. The marrow smears were made by placing immediately a small drop of the cell suspension near the frosted end of a glass slide pre-cleaned in absolute ethanol and smeared by pulling the cell suspension behind with another pre-cleaned slide at a 45° angle. The slides were quickly dried on a slide warmer set at 56°C, dipped in absolute methanol and air dried.
Stained with Giemsa.
METHOD OF ANALYSIS:
Slides were screened for good preparation, i.e. well spread, undamaged, perfectly stained.
1000 polychromatic erythrocytes (PCE)(immature) were counted for the presence of micronuclei per animal. Also the number of normochromatic erythrocytes (NCE) (mature) present in these 1000 PCE was recorded.
Data are expressed as the number of micronucleated PCE versus total normal PCE in 1000 PCE per animal.
A total of 1000 PCE and NCE was also counted per animal. These data were expressed as the ratio PCE/NCE.
OTHER: Slides were coded randomly by study number and number designation. The code was kept on a separate sheet until the slides were evaluated. Following evaluation, slides were decoded. Coding of the slides was carried out by an individual not involved in the actual scoring. - Evaluation criteria:
- If the spontaneous rate of micronuclei in the PCE is less than 0.2% and the positive control is statistically greater (p<0.05) than the spontaneous rate and at least seven animals per group survived the treatment, the results are deemed acceptable.
- Statistics:
- - one-tailed t-tests were used to make pairwise comparisons between each treatment group and its concurrent vehicle control for statistically significant increases in the number of micronucleated PCE.
- the proportion of PCE per 1000 erythrocytes per animal were evaluated by pairwise two-tailed t-tests after an arcsin transformation was performed.
All comparisons were made for each sacrifice time separately comparing treated groups versus the vehicle control group.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- abnormal gait, decreased activity, piloerection, decreased body tone, no mortality observed
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The substance did not produce any statistically significant increases in the number of micronucleated PCEs. There was a significant increase in PCE/NCE ratios for the 72h treated group as compared to the vehicle control. However, biological significance of this positive result, if any, is unknown.
RESULTS OF RANGE-FINDING STUDY
- Dose range: 10 - 2000 mg/kg
- Clinical signs of toxicity in test animals:
all mice died from 200 mg/kg up to 2000 mg/kg dose groups.
no mice died at the three lower dose groups.
100 g/kg: writhing, abnormal gait, decreased activity (immediately after treatment), decreased body tone, piloerection, abnormal gait and decreased activity (all, at 24h, 48h, 72h), abnormal stance, tremors, ptosis, cyanosis and hypothermia (1 female, 72h after treatment)
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay):
total micronucleated PCE: 17/10000 (30h), 9/10000 (48h), 15/10000 (72h), 14/10000 (neg control), 462/10000 (pos control)
- Ratio of PCE/NCE (for Micronucleus assay):
1.031 (30h), 1.384 (48h), 1.711 (72h), 1.191 (neg control), 0.758 (pos control)
- Appropriateness of dose levels and route: no data
- Statistical evaluation:
results of positive control are statistically different from results of negative control (induction of micronuclei and PCE/NCE ratio)
number of induced micronuclei is not statistically different from negative control.
PCE/NCE ratio is statistically different from negative control, only at 72h sacrifice time.
Applicant's summary and conclusion
- Conclusions:
- The substance, at 75 mg/kg bw, was considered negative in the micronucleus test at the time intervals evaluated under the experimental conditions of this assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.